Blog

Fatal Risks for Diabetes Drug Avandia Highlighted … Again

The Food and Drug Administration requested that Avandia’s maker, GlaxoSmithKline, add the strongest warnings about fatal heart attacks among users of the medication in 2007. Now, Public Citizen is highlighting liver problems from taking the diabetes type 2 drug Avandia, which is also known as rosiglitazone. Data published in the journal Pharmacoepidemiology & Drug Safety…

read more